26P Lipidic and T cell characterization as prognostic biomarkers for patients with ER+ HER2- metastatic breast cancer (MBC) treated with CDK4/6 inhibitors (CDK4/6i)
Saved in:
Published in: | ESMO open Vol. 9; p. 103034 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Ltd
01-05-2024
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
ISSN: | 2059-7029 2059-7029 |
---|---|
DOI: | 10.1016/j.esmoop.2024.103034 |